| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,775 |
1,383 |
$67K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
279 |
216 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
106 |
85 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
225 |
170 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
401 |
175 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
49 |
44 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
125 |
99 |
$929.45 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
17 |
13 |
$136.21 |
| 87807 |
|
17 |
13 |
$63.80 |
| 99072 |
|
68 |
49 |
$0.00 |
| 96127 |
|
69 |
53 |
$0.00 |